| Literature DB >> 35097436 |
Marvin Carr1, David Dye1,2, Wade Arthur1, Ryan Ottwell1, Byron Detweiler3, Wesley Stotler4, Bryan Hawkins5, Drew N Wright6, Micah Hartwell1,7, Suhao Chen8, Zhuqi Miao9, Matt Vassar1,7.
Abstract
BACKGROUND: Approximately 18 in every 100 000 people have experienced a ruptured Achilles tendon. Despite the prevalence of this condition, treatment options remain contested. HYPOTHESIS/Entities:
Keywords: Achilles tendon; meta-analysis; rupture; systematic review
Year: 2021 PMID: 35097436 PMCID: PMC8702684 DOI: 10.1177/24730114211000637
Source DB: PubMed Journal: Foot Ankle Orthop ISSN: 2473-0114
Figure 1.Search strategies to obtain systematic reviews.
Spin Types and Frequencies (%) in Abstracts (n = 43).
| Nine Most Severe Types of Spin | No. (%) of Abstracts Containing Spin |
|---|---|
| 1. Conclusion contains recommendations for clinical practice not supported by the findings. | 3 (7.0) |
| 2. Title claims or suggests a beneficial effect of the experimental intervention not supported by the findings. | 0 (0) |
| 3. Selective reporting of or overemphasis on efficacy outcomes or analysis favoring the beneficial effect of the experimental intervention. | 23 (53.5) |
| 4. Conclusion claims safety based on non–statistically significant results with a wide confidence interval. | 1 (5.3)a |
| 5. Conclusion claims the beneficial effect of the experimental treatment despite high risk of bias in primary studies. | 7 (16.3) |
| 6. Selective reporting of or overemphasis on harm outcomes or analysis favoring the safety of the experimental intervention. | 4 (9.3) |
| 7. Conclusion extrapolates the review’s findings to a different intervention (ie, claiming efficacy of 1 specific intervention although the review covers a class of several interventions). | 0 (0) |
| 8. Conclusion extrapolates the review’s findings from a surrogate marker or a specific outcome to the global improvement of the disease. | 0 (0) |
| 9. Conclusion claims the beneficial effect of the experimental treatment despite reporting bias. | 0 (0) |
a As a result of 24 studies not investigating interventions necessitating safety outcomes or measures, n = 19.
Figure 2.Flow diagram.
General Characteristics of Systematic Reviews and Meta-analyses.
| Characteristics | No. (%) of Articles (n = 43) | |||
|---|---|---|---|---|
| Total (%) | Abstract Without Spin | Abstract With Spin |
| |
| Intervention type | .45a | |||
| Mixed | 0 (0) | 0 (0) | 0 (0) | |
| Nonpharmacologic | 10 (23.3) | 2 (4.7) | 8 (18.6) | |
| Pharmacologic | 0 (0) | 0 (0) | 0 (0) | |
| Surgery | 33 (76.7) | 13 (30.2) | 20 (46.5) | |
| Article reports adherence to PRISMA | .51b | |||
| No | 23 (53.5) | 7 (16.3) | 16 (37.2) | |
| Yes | 20 (46.5) | 8 (18.6) | 12 (27.9) | |
| Publishing journal recommends adherence to PRISMA | .64b | |||
| No | 25 (58.1) | 8 (18.6) | 17 (39.5) | |
| Yes | 18 (41.9) | 7 (16.3) | 11 (25.6) | |
| Funding source | .20a | |||
| Not funded | 18 (41.9) | 4 (9.3) | 14 (32.6) | |
| Private | 0 (0) | 0 (0) | 0 (0) | |
| Combination of funding including industry | 1 (2.3) | 1 (2.3) | 0 (0) | |
| Combination of funding not including industry | 0 (0) | 0 (0) | 0 (0) | |
| Public | 6 (14.0) | 3 (7.0) | 3 (7.0) | |
| Not mentioned | 17 (39.5) | 6 (14.0) | 11 (25.6) | |
| Industry | 1 (2.3) | 1 (2.3) | 0 (0) | |
| AMSTAR-2 rating | .79a | |||
| High | 0 (0) | 0 (0) | 0 (0) | |
| Moderate | 14 (32.6) | 6 (14.0) | 8 (18.6) | |
| Low | 14 (32.6) | 4 (9.3) | 10 (23.3) | |
| Critically low | 15 (34.9) | 5 (11.6) | 10 (23.3) | |
| Journal Impact Factor, M (SD) | 4.09 (4.66) | 3.95 (2.75) | 4.18 (5.58) | .88c (OR: 1.01; 95% CI: 0.88-1.17) |
| Year study was received (1997-2020) | .67c (OR: 0.97; 95% CI: 0.84-1.11) | |||
Abbreviations: AMSTAR-2, A Measurement Tool to Assess Systematic Reviews–2; CI, confidence interval; M, mean; OR, odds ratio; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
a Fisher exact test.
b Pearson χ2.
c Logistic regression
AMSTAR-2 Items and Frequency of Responses.
| AMSTAR-2 Item | Response, n (%) | ||
|---|---|---|---|
| Yes | No | Partial Yes | |
| 1. Did the research questions and inclusion criteria for the review include the elements of PICO? | 42 (97.7) | 1 (2.3) | 0 (0) |
| 2. Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? | 7 (16.3) | 31 (72.1) | 5 (11.6) |
| 3. Did the review authors explain their selection of the study designs for inclusion in the review? | 8 (18.6) | 35 (81.4) | 0 (0) |
| 4. Did the review authors use a comprehensive literature search strategy? | 3 (7.0) | 13 (30.2) | 27 (62.8) |
| 5. Did the review authors perform study selection in duplicate? | 28 (65.1) | 15 (34.9) | 0 (0) |
| 6. Did the review authors perform data extraction in duplicate? | 24 (55.8) | 19 (44.2) | 0 (0) |
| 7. Did the review authors provide a list of excluded studies and justify the exclusions? | 1 (2.3) | 42 (97.7) | 0 (0) |
| 8. Did the review authors describe the included studies in adequate detail? | 5 (11.6) | 1 (2.3) | 37 (86.0) |
| 9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? | 26 (60.5) | 15 (34.9) | 2 (4.7) |
| 10. Did the review authors report on the sources of funding for the studies included in the review? | 22 (51.2) | 21 (48.8) | 0 (0) |
| 11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results?a | 24 (55.8) | 2 (4.7) | 0 (0) |
| 12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?a | 20 (46.5) | 6 (14.0) | 0 (0) |
| 13. Did the review authors account for RoB in primary studies when interpreting/discussing the results of the review? | 25 (58.1) | 18 (41.9) | 0 (0) |
| 14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? | 24 (55.8) | 19 (44.2) | 0 (0) |
| 15. If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?a | 10 (23.3) | 16 (37.2) | 0 (0) |
| 16. Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review | 30 (69.8) | 13 (30.2) | 0 (0) |
Abbreviations: AMSTAR-2, A Measurement Tool to Assess Systematic Reviews–2; PICO, Population, Intervention, Comparator group, Outcome (PICO) method.
a Seventeen articles did not perform a meta-analysis.